廣告
香港股市 已收市

  • 恒指

    19,553.61
    +177.08 (+0.91%)
     

  • 國指

    6,934.70
    +63.32 (+0.92%)
     

  • 上證綜指

    3,154.03
    +31.63 (+1.01%)
     

  • 滬深300

    3,677.97
    +37.61 (+1.03%)
     

  • 美元

    7.8013
    +0.0006 (+0.01%)
     

  • 人民幣

    0.9258
    +0.0010 (+0.11%)
     

  • 道指

    39,869.38
    -38.62 (-0.10%)
     

  • 標普 500

    5,297.10
    -11.05 (-0.21%)
     

  • 納指

    16,698.32
    -44.07 (-0.26%)
     

  • 日圓

    0.0498
    -0.0002 (-0.32%)
     

  • 歐元

    8.4587
    -0.0181 (-0.21%)
     

  • 英鎊

    9.8680
    -0.0140 (-0.14%)
     

  • 紐約期油

    79.29
    +0.06 (+0.08%)
     

  • 金價

    2,392.80
    +7.30 (+0.31%)
     

  • Bitcoin

    66,183.01
    -164.72 (-0.25%)
     

  • CMC Crypto 200

    1,350.51
    -23.33 (-1.70%)
     

Here's Why Becton Dickinson (BDX) is a Strong Value Stock

Zacks Equity Research
·2 分鐘文章

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.

Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.

Why Investors Should Pay Attention to This Value Stock

Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks.

廣告

Becton Dickinson (BDX)

Based in Franklin Lakes, NJ, Becton, Dickinson and Company, commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents.

BDX is a Zacks Rank #2 (Buy) stock, with a Value Style Score of B and VGM Score of B. Shares are currently trading at a forward P/E of 18.1X for the current fiscal year compared to the Medical - Dental Supplies industry's P/E of 17.6X. Additionally, BDX has a PEG Ratio of 1.9 and a Price/Cash Flow ratio of 11.6X. Value investors should also note BDX's Price/Sales ratio of 3.5X.

A company's earnings performance is important for value investors as well. For fiscal 2024, one analyst revised their earnings estimate higher in the last 60 days for BDX, while the Zacks Consensus Estimate has increased $0.00 to $12.94 per share. BDX also holds an average earnings surprise of 4.6%.

BDX should be on investors' short lists because of its impressive earnings and valuation fundamentals, a good Zacks Rank, and strong Value and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Becton, Dickinson and Company (BDX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research